Rheinmetall AG is a holding company, which engages in the provision of development and sale of components, systems, and services for the security and civil industries. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 31,923 full-time employees. The company went IPO on 2008-02-25. The Company’s focus is on security technology and mobility solutions. The company operates through two segments and five divisions such as defense and automotive segments. The vehicle systems, electronic solutions and weapon and ammunition divisions are operating under security and defense segment and the sensors and actuators and materials and trade divisions supply under automotive segment. The vehicle systems division activity areas are armored tracked vehicles, chemical, biological, radiological and nuclear protection equipment. The weapon and ammunition providing activities in weapons and munitions, propellants, protection systems. The electronic solutions operating areas are air defense systems, soldier systems, command, control and reconnaissance systems, fire control systems. The material and trade operate in engine blocks, structural components and cylinder heads, plain bearings. The sensors and actuators operate in emissions reduction.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Hasılat
117
22
37
30
26
22
Hasılat Artışı (YoY)
17%
0%
37%
20%
4%
-19%
Satınalma Maliyeti
5
1
1
1
1
0
Brüt Kâr
111
21
35
28
25
21
Satış, Genel ve İdari
91
21
30
19
20
15
Araştırma ve Geliştirme
17
6
4
2
3
3
İşletme Giderleri
108
28
35
22
23
18
Diğer Finansman Gelirleri (Giderleri)
-1
0
-1
0
0
2
Kâr Öncesi Gelir
0
-9
0
7
2
4
Kira Vergisi Gideri
4
0
1
1
0
0
Net Kâr
-6
-8
-1
3
0
2
Net Income Growth
Kâr Artışı
-186%
-500%
--
200%
-100%
-71%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
91.31
91.31
91.25
103.97
102.7
101.97
Hisse Değişimi (Yıllık Üst Üste)
-10%
-10%
6%
1%
-2%
-1%
EPS (Diluted)
-0.07
-0.09
-0.01
0.03
0
0.02
EPS Artışı
-202.99%
-459%
1,475%
164%
-87%
-64%
Öz sermaye akışı
3
2
-5
3
1
0
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
94.87%
95.45%
94.59%
93.33%
96.15%
95.45%
Faaliyet Kâr Marjı
1.7%
-27.27%
0%
20%
7.69%
9.09%
Kâr Marjı
-5.12%
-36.36%
-2.7%
10%
0%
9.09%
Özsermaye Karlılık Oranı
2.56%
9.09%
-13.51%
10%
3.84%
0%
EBITDA
4
-6
0
6
2
2
EBITDA Marjinali
3.41%
-27.27%
0%
20%
7.69%
9.09%
D&A EBITDA için
2
0
0
0
0
0
Faaliyet Kârı
2
-6
0
6
2
2
Faaliyet Kâr Marjı
1.7%
-27.27%
0%
20%
7.69%
9.09%
Verilen Vergi Oranı
0%
0%
0%
14.28%
0%
0%
Follow-Up Questions
Rheinmetall AG'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Gyre Therapeutics Inc'in toplam varlıkları $0 olup, net kayıp $0'dir.
RNMBY'ün temel finansal oranları nelerdir?
Gyre Therapeutics Inc'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.
Rheinmetall AG'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Gyre Therapeutics Inc en büyük gelir kaynağı Gyre Pharmaceuticals olup, en son kar bildiriminde geliri 116,588,000 dir. Coğrafi olarak, China , Gyre Therapeutics Inc için ana pazar olup, geliri 116,588,000 dir.
Rheinmetall AG kârlı mı?
hayır, son mali tablolara göre Gyre Therapeutics Inc'in net kayıp $0'dir.
Rheinmetall AG'in herhangi bir yükümlülüğü var mı?